News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Bhavina Sharma MD

Articles by Bhavina Sharma MD

This trial combines pembrolizumab and trabedersen to enhance treatment for advanced NSCLC, targeting TGF-β2 for improved patient outcomes.

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC

ByOmar K. Abughanimeh, MBBS,Anthony E. Maida III, PhD, MA, MBA,Sanjive Qazi, PhD,Kate-Lynn Muir, DO,Bhavina Sharma MD,Lynette Smith, PhD,Apar Kishor Ganti, MD

October 30th 2025

Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman

BySamia Asif, MBBS,Brendan J. Hurley, MD,Sehr Haroon, MD,Subodh Lele, MD,Bhavina Sharma MD

October 12th 2023

A young woman presents with painless lumps to the emergency department and is later diagnosed with clear cell carcinoma.

Latest Updated Articles

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
Published: October 30th 2025 | Updated:
Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman
Published: October 12th 2023 | Updated:

Trending on CancerNetwork

Chlorotoxin-Based Therapy Shows Safety, Feasibility in Glioblastoma

Pembrolizumab Regimen May Show Synergy in Melanoma Populations

Ezabenlimab Combo Yields Activity in Advanced Squamous Cell Anal Carcinoma

Radioembolization Plus Chemotherapy Is Feasible in Liver-Dominant NETs

Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC

© 2025 MJH Life Sciences^®

All rights reserved.